e-learning
resources
ERJ
2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Keratinocyte growth factor prevents intra-alveolar oedema in experimental lung isografts
Sadovski J., Kuchenbuch T., Ruppert C., Fehrenbach A., Hirschburger M., Padberg W., Gunther A., Hohlfeld J. M., Fehrenbach H., Grau V.
Source:
Eur Respir J 2008; 31: 21-28
Journal Issue:
January
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sadovski J., Kuchenbuch T., Ruppert C., Fehrenbach A., Hirschburger M., Padberg W., Gunther A., Hohlfeld J. M., Fehrenbach H., Grau V.. Keratinocyte growth factor prevents intra-alveolar oedema in experimental lung isografts. Eur Respir J 2008; 31: 21-28
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Keratinocyte growth factor (rHuKGF) increases surfactant protein A in rats and prevents alveolar oedema after orthotopic rat lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 779s
Year: 2006
Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats
Source: Eur Respir J 2007; 30: 31-39
Year: 2007
Epidermal growth factor in the lungs of infants developing chronic lung disease
Source: Eur Respir J 2001; 18: 796-800
Year: 2001
Hepatocyte growth factor (HGF) in lung allografts
Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Year: 2005
Antifibrotic role of hepatocyte growth factor (HGF) in fibrosing interstial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 367s
Year: 2001
Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007
Electroporation of Hepatocyte growth factor to the lung induces migration of bone marrow mesenchymal stem cells and reduces lung fibrosis
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018
Enhancement of neutrophil function by the bronchial epithelium stimulated by epidermal growth factor
Source: Eur Respir J 2008; 31: 714-724
Year: 2008
Imbalance between vascular endothelial growth factor and endostatin in emphysema
Source: Eur Respir J 2003 Oct 01;22(4):609-612
Year: 2003
Fibroblast growth factor 9 (FGF9) modulates the phenotype of control and fibrotic human lung fibroblasts
in vitro
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Role of Bcl-xL in hepatocyte growth factor elicited epithelial protection in idiopathic lung fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013
Changes and significance of hepatoma-derived growth factor and vascular endothelial growth factor in serum and lung tissue from patients with lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis.
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018
Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF
Source: Eur Respir J 2001; 17: 1220-1227
Year: 2001
Fibroblast growth factor 9 (FGF9) modulates mesothelial cells plasticity to decrease differentiation and migration in vitro
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro
Source: Eur Respir J 2002; 20: 1449-1456
Year: 2002
Connective tissue growth factor (CTGF) induces lung fibrosis in otherwise fibrosis-resistant Balb/c mouse in a bleomycin model
Source: Eur Respir J 2004; 24: Suppl. 48, 104s
Year: 2004
Vascular endothelial growth factor (VEGF) mRNA isoforms in an animal model of acute lung injury
Source: Annual Congress 2003 - Animal models of lung injury: useful or not?
Year: 2003
Increased recipient VEGF serum level is a risk factor for severe reperfusion edema after lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 706s
Year: 2005
Modulating progenitor accumulation attenuates lung angiogenesis in a mouse model of asthma
Source: Eur Respir J 2011; 38: 679-687
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept